FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130406507> ?p ?o ?g. }

• W2130406507 endingPage "319" @default.
• W2130406507 startingPage "309" @default.
• W2130406507 abstract "Familial combined hyperlipoproteinemia (FCH) is a common familial lipoprotein disorder characterized by elevated plasma cholesterol and triglyceride levels with segregation in first-degree relatives. Most affected subjects with FCH have elevated plasma levels of apolipoprotein (apo) B. The disorder results from oversecretion of hepatic apoB-containing lipoprotein particles. The genetic defect(s) are unknown. Previous work has suggested that genetic polymorphisms of the apoA-I gene and functional abnormalities of the lipoprotein lipase (LPL) gene are associated with FCH. We investigated the XmnI and SstI restriction fragment length polymorphisms (RFLP) of the apoA-I gene in FCH subjects of French Canadian descent. We also investigated three common functional mutations of the lipoprotein lipase (LPL) gene (LPLGly188Glu, LPLPro207Leu, and LPLAsp250Asn) in French Canadians that account for approximately 97% of cases of complete LPL deficiency in the province of Quebec, Canada. We identified and characterized 54 FCH probands in lipid clinics and examined at least one first-degree relative. There were 37 men and 17 women (mean age 48 +/- 9 and 58 +/- 8 years, respectively). None of the probands had diabetes mellitus; mean plasma glucose was 5.5 mmol/L. High blood pressure was diagnosed in 32% of men and 29% of women. The body mass index (weight (kg)/height(m2)) was elevated in probands (27 +/- 4 for men and 26 +/- 4 for women). Mean plasma levels of cholesterol (C) was 7.6 +/- 1.5 mmol/L, triglycerides 3.5 +/- 1.6 mmol/L, LDL-C 4.9 +/- 1.2 mmol/L, HDL-C 1.0 +/- 0.3 mmol/L, and apoB 1.83 +/- 0.67 g/L in the probands. Allele frequency of the rare alleles of the XmnI and SstI RFLP was not significantly different from a healthy reference group. In several families studied, the XmnI and SstI RFLP did not unequivocally segregate with the FCH phenotype. There was no significant effect of the presence or absence of the XmnI or SstI RFLP's on plasma lipids, lipoprotein cholesterol or apoB levels. Only one FCH proband was found to have a mutation of the LPL gene (Gly188Glu), and this did not segregate with the FCH phenotype in the family. We conclude that in our highly selected group of FCH subjects of French Canadian descent, the XmnI and SstI RFLPs of the apoA-I gene and common functional mutations of the LPL gene resulting in complete LPL deficiency are not associated with FCH." @default.
• W2130406507 created "2016-06-24" @default.
• W2130406507 creator A5021267882 @default.
• W2130406507 creator A5022102417 @default.
• W2130406507 creator A5053442157 @default.
• W2130406507 creator A5058992883 @default.
• W2130406507 creator A5070770963 @default.
• W2130406507 creator A5077468402 @default.
• W2130406507 date "1996-02-01" @default.
• W2130406507 modified "2023-10-17" @default.
• W2130406507 title "Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects" @default.
• W2130406507 cites W1499889283 @default.
• W2130406507 cites W1500471999 @default.
• W2130406507 cites W1506255962 @default.
• W2130406507 cites W1534027430 @default.
• W2130406507 cites W1557907146 @default.
• W2130406507 cites W1933275042 @default.
• W2130406507 cites W1973178110 @default.
• W2130406507 cites W1976064433 @default.
• W2130406507 cites W1980936469 @default.
• W2130406507 cites W1991181799 @default.
• W2130406507 cites W1999005586 @default.
• W2130406507 cites W2000299078 @default.
• W2130406507 cites W2006075540 @default.
• W2130406507 cites W2007542782 @default.
• W2130406507 cites W2012305341 @default.
• W2130406507 cites W2014670571 @default.
• W2130406507 cites W2015776407 @default.
• W2130406507 cites W2017923274 @default.
• W2130406507 cites W2026911242 @default.
• W2130406507 cites W2032118018 @default.
• W2130406507 cites W2037408127 @default.
• W2130406507 cites W2040171866 @default.
• W2130406507 cites W2042436608 @default.
• W2130406507 cites W2057394745 @default.
• W2130406507 cites W2077406306 @default.
• W2130406507 cites W2078707204 @default.
• W2130406507 cites W2081860696 @default.
• W2130406507 cites W2082089394 @default.
• W2130406507 cites W2086258039 @default.
• W2130406507 cites W2087571100 @default.
• W2130406507 cites W2092823680 @default.
• W2130406507 cites W2096773810 @default.
• W2130406507 cites W2105732728 @default.
• W2130406507 cites W2110189202 @default.
• W2130406507 cites W2116890637 @default.
• W2130406507 cites W2118310760 @default.
• W2130406507 cites W2129079051 @default.
• W2130406507 cites W2142802148 @default.
• W2130406507 cites W2146319058 @default.
• W2130406507 cites W2148612567 @default.
• W2130406507 cites W2156068102 @default.
• W2130406507 cites W2158360813 @default.
• W2130406507 cites W2182397397 @default.
• W2130406507 cites W2186479551 @default.
• W2130406507 cites W2189071838 @default.
• W2130406507 cites W2337024947 @default.
• W2130406507 cites W2402354430 @default.
• W2130406507 cites W2991843266 @default.
• W2130406507 cites W4244586896 @default.
• W2130406507 doi "https://doi.org/10.1016/s0022-2275(20)37618-5" @default.
• W2130406507 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9026529" @default.
• W2130406507 hasPublicationYear "1996" @default.
• W2130406507 type Work @default.
• W2130406507 sameAs 2130406507 @default.
• W2130406507 citedByCount "37" @default.
• W2130406507 countsByYear W21304065072012 @default.
• W2130406507 countsByYear W21304065072013 @default.
• W2130406507 countsByYear W21304065072015 @default.
• W2130406507 countsByYear W21304065072016 @default.
• W2130406507 crossrefType "journal-article" @default.
• W2130406507 hasAuthorship W2130406507A5021267882 @default.
• W2130406507 hasAuthorship W2130406507A5022102417 @default.
• W2130406507 hasAuthorship W2130406507A5053442157 @default.
• W2130406507 hasAuthorship W2130406507A5058992883 @default.
• W2130406507 hasAuthorship W2130406507A5070770963 @default.
• W2130406507 hasAuthorship W2130406507A5077468402 @default.
• W2130406507 hasBestOaLocation W21304065071 @default.
• W2130406507 hasConcept C104317684 @default.
• W2130406507 hasConcept C126322002 @default.
• W2130406507 hasConcept C134018914 @default.
• W2130406507 hasConcept C171089720 @default.
• W2130406507 hasConcept C2778163477 @default.
• W2130406507 hasConcept C2780072125 @default.
• W2130406507 hasConcept C54355233 @default.
• W2130406507 hasConcept C62746215 @default.
• W2130406507 hasConcept C71924100 @default.
• W2130406507 hasConcept C86803240 @default.
• W2130406507 hasConcept C94879076 @default.
• W2130406507 hasConceptScore W2130406507C104317684 @default.
• W2130406507 hasConceptScore W2130406507C126322002 @default.
• W2130406507 hasConceptScore W2130406507C134018914 @default.
• W2130406507 hasConceptScore W2130406507C171089720 @default.
• W2130406507 hasConceptScore W2130406507C2778163477 @default.
• W2130406507 hasConceptScore W2130406507C2780072125 @default.
• W2130406507 hasConceptScore W2130406507C54355233 @default.
• W2130406507 hasConceptScore W2130406507C62746215 @default.
• W2130406507 hasConceptScore W2130406507C71924100 @default.

• next